Diseases & Disorders
(G30)
IRS Verified
DX Registered
990 on File
CURE BREAST CANCER FOUNDATION INC
Financial strength (30%)
57/100
Reliability (20%)
50/100
Effectiveness (25%)
48/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
Breast cancer is one of the leading causes of death among women, yet its cure has remained unresolved. That may be about to change. Cure Breast Cancer Foundation (CBCF) is a 501(c)(3) not-for-profit organization created to raise money for breast cancer research under the direction of noted oncologist, Dr. Larry Norton, at the world-renowned Memorial Sloan-Kettering Cancer Center and other national and international research facilities. Since its inception in December 2007, CBCF has raised over $5 million for breast cancer research.
Financial Overview — FY 2023
$516K
Total Revenue
$157K
Total Expenses
$3.6M
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
0.0%
Fundraising Efficiency
30.3%
Operating Reserve
278.26x
Liability-to-Asset
0.0%
Revenue Diversification
95.7%
Compared with Peers
FY 2023
Compared with 2,093 similar organizations
(United States, Diseases & Disorders, $100K–$1M in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
0.0% | 83.4% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
87.6% | 11.3% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
12.4% | 0.1% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
30.3% | 18.4% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
278.3 mo | 12.3 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.9% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
95.7% | 95.3% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
-7.2% | 9.5% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-59.2% | 14.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
69.5% | 0.9% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $516K | $157K | $3.6M | 0.0% | 0 |
| 2022 | $557K | $386K | $3.2M | 64.8% | 0 |
| 2021 | $596K | $356K | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.